Big step forward for Actorius Innovations and Research 🙌

Actorius recently signed an MOU with Advanced Centre for Treatment, Research and Education in Cancer(ACTREC) to collaborate on clinical studies and research spanning - practical utility of Circulating Tumor Cells and their capture and depletion from patient’s blood as possible aid to adjunct therapeutics.

Slowing down or blocking metastasis cascade in early stage patients.

Extremely bold and breakthrough innovation hypothesis.

This partnership is about taking science closer to patients—generating meaningful real-world evidence, strengthening translational research, and asking the right clinical questions where it truly matters.

The MOU was signed by Dr. Pankaj Chaturvedi, Director, ACTREC, and Dr. Jayant Khandare, Co-Founder & CSO, Actorius Innovations and Research.

Excited about what lies ahead and the impact this collaboration can create together.

Aravindan Vasudevan Rick Kamble